Literature DB >> 7817479

Resolution time of Escherichia coli cystitis is correlated with levels of preinfection antibody to the infecting Escherichia coli strain.

W J Hopkins1, D T Uehling.   

Abstract

OBJECTIVES: A number of studies in animals have demonstrated that immunization against uropathogenic bacteria can lessen the severity or duration of induced urinary tract infections (UTI). This study examined whether preinfection levels of serum or urinary anti-Escherichia coli antibodies were correlated with length of time needed to resolve an induced E coli cystitis.
METHODS: Serum and urine anti-E coli antibody levels in 36 control and 42 vaginally immunized cynomolgus monkeys were measured by enzyme-linked immunosorbent assay. Regression analyses were used to determine correlations between resolution time and preinfection antibody level, and to estimate antibody levels that might be associated with effective resolution of an E coli UTI.
RESULTS: Linear regression analysis showed significant correlations between short resolution time and high levels of serum immunoglobulin M (IgM), urinary secretory IgA, and urinary IgG specific for the infecting E coli strain. Serum IgM and urinary IgG anti-E coli levels in monkeys that cleared infections early were significantly higher than in animals with protracted infections. Logistic regression estimated the serum IgM and urinary IgG anti-E coli levels associated with a 50% probability of accelerated clearance to be 3.3 micrograms/mL and 2.7 micrograms/24 hours, respectively.
CONCLUSIONS: For this primate model, the observed correlations between short resolution time and pre-existing serum and urinary antibody suggest that antibody-mediated immunity is an important component of host defense against UTI.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7817479     DOI: 10.1016/s0090-4295(95)96444-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.

Authors:  W J Hopkins; A Gendron-Fitzpatrick; E Balish; D T Uehling
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection.

Authors:  Erin C Hagan; Harry L T Mobley
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

3.  Lipopolysaccharide-responder and nonresponder C3H mouse strains are equally susceptible to an induced Escherichia coli urinary tract infection.

Authors:  W Hopkins; A Gendron-Fitzpatrick; D O McCarthy; J E Haine; D T Uehling
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

4.  Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.

Authors:  Praveen Alamuri; Kathryn A Eaton; Stephanie D Himpsl; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2008-11-24       Impact factor: 3.441

5.  Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia coli Isolate.

Authors:  Jingyu Diao; Catrien Bouwman; Donghong Yan; Jing Kang; Anand K Katakam; Peter Liu; Homer Pantua; Alexander R Abbas; Nicholas N Nickerson; Cary Austin; Mike Reichelt; Wendy Sandoval; Min Xu; Chris Whitfield; Sharookh B Kapadia
Journal:  MBio       Date:  2017-05-23       Impact factor: 7.867

6.  Mucosal immunization with iron receptor antigens protects against urinary tract infection.

Authors:  Christopher J Alteri; Erin C Hagan; Kelsey E Sivick; Sara N Smith; Harry L T Mobley
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.